Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Aranesp® (darbepoetin alfa) – New warning
October 31, 2017 – The FDA approved an update to the Warnings and Precautions section of the Aranesp (darbepoetin alfa) drug label regarding severe cutaneous reactions.
